In his capacity as immediate past president of the Federation of Associations of Behavioral and Brain Sciences, Jeremy Wolfe interviews Mike Lauer about the new NIH clinical trials policy. Mike Lauer is NIH’s deputy director for extramural research, serving as the principal scientific leader and advisor to the NIH director on the extramural research programme.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.M.W. is currently funded by the NIH. He does not have any current advisory role with the NIH though he has previously served as a grant reviewer and study section member. He has no involvement in setting the clinical trial policy changes or their implementation.
Rights and permissions
About this article
Cite this article
Wolfe, J.M. In dialogue with the NIH on clinical trials policy. Nat Hum Behav 2, 100–102 (2018). https://doi.org/10.1038/s41562-018-0303-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41562-018-0303-x
This article is cited by
-
Diverse views show pathways to improvement
Nature Human Behaviour (2018)